A systematic review of humoral immune responses against tumor antigens Miriam ReuschenbachMagnus von Knebel DoeberitzNicolas Wentzensen Review 28 June 2009 Pages: 1535 - 1544
Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity Ussama M. Abdel-MotalKim WigglesworthUri Galili Original Article 28 January 2009 Pages: 1545 - 1556
Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases Thomas Josef VoglThaddäus T. WissniowskiJohannes Hänsler Original Article 29 January 2009 Pages: 1557 - 1563
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2 Hanh K. LeLaura GrahamHarry Douglas Bear Original Article 06 February 2009 Pages: 1565 - 1576
Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β Taku NagaiMasashi TanakaTakami Matsuyama Original Article 24 February 2009 Pages: 1577 - 1586
Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses Jun ZhouDesheng WengJianchuan Xia Original Article 17 February 2009 Pages: 1587 - 1597
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma Hildur HelgadottirEmilia AnderssonGiuseppe Valentino Masucci Original Article 13 February 2009 Pages: 1599 - 1608
Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination Jon Amund KyteSissel TrachselGustav Gaudernack Original Article 17 February 2009 Pages: 1609 - 1626
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model Claire BanissiFrançois GhiringhelliAntoine F. Carpentier Original Article 17 February 2009 Pages: 1627 - 1634
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells Craig GedyeJuliet QuirkIan D. Davis Original Article 17 February 2009 Pages: 1635 - 1646
Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro Wujiang LiuMichael A. O’DonnellYi Luo Original Article 13 February 2009 Pages: 1647 - 1655
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4) Eyad ElkordAdam DangoorPeter L. Stern Original Article 17 February 2009 Pages: 1657 - 1667
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response Stéphanie DellucPatricia HachemAgnès Buzyn Original Article 19 February 2009 Pages: 1669 - 1677
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4+ T cells in a subset of cultures Wendy IngramShahram KordastiFarzin Farzaneh Original Article 13 March 2009 Pages: 1679 - 1690
Anti-cancer activity and mechanistic features of a NK cell activating molecule Hyung-Ran KimKyoung-Ho LeeJongsun Kim Original Article 04 March 2009 Pages: 1691 - 1700
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium Cedrik Michael BrittenSylvia Janetzkifor the HLA-peptide Multimer Proficiency Panel of the CVC-CRI Immune Assay Working Group Original Article Open access 04 March 2009 Pages: 1701 - 1713
Treatment of non-Hodgkin’s lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy Robert T. O’DonnellDavid PearsonJoseph M. Tuscano Short Communication 18 March 2009 Pages: 1715 - 1722